The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Global landscape of protein complexes in the yeast Saccharomyces cerevisiae
Krogan, N. J., Cagney, G., Yu, H., Zhong, G., Guo, X., Ignatchenko, A., Li, J., Pu, S., Datta, N., Tikuisis, A. P., et al. (2006) · Nature · doi:10.1038/nature04670 · Cited by 2,952
Principles of protein-protein interactions
Jones, S., & Thornton, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.13 · Cited by 2,684
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
A Hot Spot of Binding Energy in a Hormone-Receptor Interface
Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,983
Self-citationThe atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,964
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
Self-citationStructure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis
Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., et al. (1997) · Science · doi:10.1126/science.275.5302.983 · Cited by 1,476
Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349
Refined structure of αβ-tubulin at 3.5 Å resolution 1 1Edited by I. A. Wilson
Löwe, J., Li, H., Downing, K. H., & Nogales, E. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5077 · Cited by 1,145
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
Gao, Y., Dickerson, J. B., Guo, F., Zheng, J., & Zheng, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307512101 · Cited by 1,091
Collins, S. R., Miller, K. M., Maas, N. L., Roguev, A., Fillingham, J., Chu, C. S., Schuldiner, M., Gebbia, M., Recht, J., Shales, M., et al. (2007) · Nature · doi:10.1038/nature05649 · Cited by 869
The maximal affinity of ligands
Kuntz, I. D., Chen, K., Sharp, K. A., & Kollman, P. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.9997 · Cited by 849
Unraveling hot spots in binding interfaces: progress and challenges
DeLano, W. L. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00283-x · Cited by 767
Hot spots—A review of the protein–protein interface determinant amino‐acid residues
Moreira, I. S., Fernandes, P. A., & Ramos, M. J. (2007) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21396 · Cited by 760
Structure-based maximal affinity model predicts small-molecule druggability
Cheng, A. C., Coleman, R. G., Smyth, K. T., Cao, Q., Soulard, P., Caffrey, D. R., Salzberg, A. C., & Huang, E. S. (2007) · Nature Biotechnology · doi:10.1038/nbt1273 · Cited by 695
Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin
Wrighton, N. C., Farrell, F. X., Chang, R., Kashyap, A. K., Barbone, F. P., Mulcahy, L. S., Johnson, D. L., Barrett, R. W., Jolliffe, L. K., & Dower, W. J. (1996) · Science · doi:10.1126/science.273.5274.458 · Cited by 672
Convergent Solutions to Binding at a Protein-Protein Interface
DeLano, W. L., Ultsch, M. H., de, A. M., Vos, & Wells, J. A. (2000) · Science · doi:10.1126/science.287.5456.1279 · Cited by 672
Self-citationThe P53 pathway: what questions remain to be explored?
Levine, A. J., Hu, W., & Feng, Z. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401910 · Cited by 659
Small-Molecule Inhibition of TNF-α
He, M. M., Smith, A. S., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C., et al. (2005) · Science · doi:10.1126/science.1116304 · Cited by 620
Rush, T. S., Grant, J. A., Mosyak, L., & Nicholls, A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040163o · Cited by 600
Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å
Livnah, O., Stura, E. A., Johnson, D. L., Middleton, S. A., Mulcahy, L. S., Wrighton, N. C., Dower, W. J., Jolliffe, L. K., & Wilson, I. A. (1996) · Science · doi:10.1126/science.273.5274.464 · Cited by 588
Moerke, N. J., Aktas, H., Chen, H., Cantel, S., Reibarkh, M. Y., Fahmy, A., Gross, J. D., Degterev, A., Yuan, J., Chorev, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.046 · Cited by 572
A protein interaction network of the malaria parasite Plasmodium falciparum
LaCount, D. J., Vignali, M., Chettier, R., Phansalkar, A., Bell, R., Hesselberth, J. R., Schoenfeld, L. W., Ota, I., Sahasrabudhe, S., Kurschner, C., et al. (2005) · Nature · doi:10.1038/nature04104 · Cited by 524
Druggability Indices for Protein Targets Derived from NMR-Based Screening Data
Hajduk, P. J., Huth, J. R., & Fesik, S. W. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049131r · Cited by 522
Eck, M. J., & Sprang, S. R. (1990) · PubMed · doi:10.2210/pdb1tnf/pdb · Cited by 507
The Structure of Tumor Necrosis Factor-α at 2.6 Å Resolution
Eck, M. J., & Sprang, S. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71533-0 · Cited by 473
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
Yin, H., & Hamilton, A. D. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461786 · Cited by 453
Muller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., & de Vos, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7192 · Cited by 452
Self-citationDiscovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells
Grasberger, B. L., Lu, T., Schubert, C., Parks, D. J., Carver, T. E., Koblish, H. K., Cummings, M. D., LaFrance, L. V., Milkiewicz, K. L., Calvo, R. R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049137g · Cited by 432
PETROS, A. M., NETTESHEIM, D. G., WANG, Y., OLEJNICZAK, E. T., MEADOWS, R. P., MACK, J., SWIFT, K., MATAYOSHI, E. D., ZHANG, H., THOMPSON, C. B., et al. (2000) · Protein Science · doi:10.1017/s096183680000331x · Cited by 412
Visualization of transient encounter complexes in protein–protein association
Tang, C., Iwahara, J., & Clore, G. M. (2006) · Nature · doi:10.1038/nature05201 · Cited by 406
[21] Phage display for selection of novel binding peptides
Sidhu, S. S., Lowman, H. B., Cunningham, B. C., & Wells, J. A. (2000) · Methods in Enzymology · doi:10.1016/s0076-6879(00)28406-1 · Cited by 406
Self-citationBinding of small molecules to an adaptive protein–protein interface
Arkin, M. R., Randal, M., DeLano, W. L., Hyde, J., Luong, T. N., Oslob, J. D., Raphael, D. R., Taylor, L., Wang, J., McDowell, R. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252756299 · Cited by 375
Self-citationA High-Throughput Screen for Aggregation-Based Inhibition in a Large Compound Library
Feng, B. Y., Simeonov, A., Jadhav, A., Babaoglu, K., Inglese, J., Shoichet, B. K., & Austin, C. P. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061317y · Cited by 358
Fragment-based lead discovery: leads by design
Carr, R. A. E., Congreve, M., Murray, C. W., & Rees, D. C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03511-7 · Cited by 343
Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL
Bruncko, M., Oost, T. K., Belli, B. A., Ding, H., Joseph, M. K., Kunzer, A., Martineau, D., McClellan, W. J., Mitten, M., Ng, S.-C., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061152t · Cited by 304
Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x L from NMR and Parallel Synthesis
Petros, A. M., Dinges, J., Augeri, D. J., Baumeister, S. A., Betebenner, D. A., Bures, M. G., Elmore, S. W., Hajduk, P. J., Joseph, M. K., Landis, S. K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0507532 · Cited by 292
Clackson, T., Ultsch, M. H., Wells, J. A., & de Vos, A. M. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1669 · Cited by 278
Self-citationAnderson, C. M., Zucker, F. H., & Steitz, T. A. (1979) · Science · doi:10.1126/science.220706 · Cited by 277
Mosyak, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3179 · Cited by 276
Bad Is a BH3 Domain-Containing Protein That Forms an Inactivating Dimer with Bcl-X L
Kelekar, A., Chang, B. S., Harlan, J. E., Fesik, S. W., & Thompson, C. B. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7040 · Cited by 274
Discovery of a Potent Small Molecule IL-2 Inhibitor through Fragment Assembly
Braisted, A. C., Oslob, J. D., Delano, W. L., Hyde, J., McDowell, R. S., Waal, N., Yu, C., Arkin, M. R., & Raimundo, B. C. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034247i · Cited by 256
Volkov, A. N., Worrall, J. A. R., Holtzmann, E., & Ubbink, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603551103 · Cited by 248
Picksley, S. M., Vojtĕsek, B., Sparks, A., & Lane, D. P. (1994) · PubMed · Cited by 238
Fujii, N., You, L., Xu, Z., Uematsu, K., Shan, J., He, B., Mikami, I., Edmondson, L. R., Neale, G., Zheng, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2726 · Cited by 232
Antagonists of protein–protein interactions
Cochran, A. G. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00106-x · Cited by 228
Anderson, C. M., Zucker, F. H., & Steitz, T. A. (1979) · Science · Cited by 222
Transient Pockets on Protein Surfaces Involved in Protein−Protein Interaction
Eyrisch, S., & Helms, V. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070095g · Cited by 213
The Structure of Interleukin-2 Complexed with Its Alpha Receptor
Rickert, M., Wang, X., Boulanger, M. J., Goriatcheva, N., & Garcia, K. C. (2005) · Science · doi:10.1126/science.1109745 · Cited by 212
Protein–protein interactions as targets for small molecule drug discovery
Fry, D. C. (2006) · Peptide Science · doi:10.1002/bip.20608 · Cited by 206
McMillan, K., Adler, M., Auld, D. S., Baldwin, J. J., Blasko, E., Browne, L. J., Chelsky, D., Davey, D., Dolle, R. E., Eagen, K. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1506 · Cited by 201
Terphenyl-Based Bak BH3 α-Helical Proteomimetics as Low-Molecular-Weight Antagonists of Bcl-x L
Yin, H., Lee, G.-I., Sedey, K. A., Kutzki, O., Park, H. S., Orner, B. P., Ernst, J. T., Wang, H.-G., Sebti, S. M., & Hamilton, A. D. (2005) · Journal of the American Chemical Society · doi:10.1021/ja050122x · Cited by 198
Trosset, J., Dalvit, C., Knapp, S., Fasolini, M., Veronesi, M., Mantegani, S., Gianellini, L. M., Catana, C., Sundström, M., Stouten, P. F. W., et al. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20955 · Cited by 181
Protein–protein interactions and cancer: small molecules going in for the kill
Arkin, M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.03.001 · Cited by 175
Zobel, K., Wang, L., Varfolomeev, E., Franklin, M. C., Elliott, L. O., Wallweber, H. J. A., Okawa, D. C., Flygare, J. A., Vucic, D., Fairbrother, W. J., et al. (2006) · ACS Chemical Biology · doi:10.1021/cb600276q · Cited by 174
Sadowsky, J. D., Fairlie, W. D., Hadley, E. B., Lee, H.-S., Umezawa, N., Nikolovska-Coleska, Z., Wang, S., Huang, D. C. S., Tomita, Y., & Gellman, S. H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0662523 · Cited by 174
Parks, D. J., LaFrance, L. V., Calvo, R. R., Milkiewicz, K. L., Gupta, V., Lattanze, J., Ramachandren, K., Carver, T. E., Petrella, E. C., Cummings, M. D., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.11.009 · Cited by 167
Koblish, H. K., Zhao, S., Franks, C. F., Donatelli, R. R., Tominovich, R. M., LaFrance, L. V., Leonard, K. A., Gushue, J. M., Parks, D. J., Calvo, R. R., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0199 · Cited by 165
The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2
Abbate, E. A., Berger, J. M., & Botchan, M. R. (2004) · Genes & Development · doi:10.1101/gad.1220104 · Cited by 160
Carter, P. H., Scherle, P., Muckelbauer, J. A., Voss, M. E., Liu, R., Thompson, L. A., Tebben, A. J., Solomon, K. A., Lo, Y. C., Li, Z., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211178398 · Cited by 159
Thermodynamics of Binding of a Low-Molecular-Weight CD4 Mimetic to HIV-1 gp120
Schön, A., Madani, N., Klein, J. C., Hubicki, A. M., Ng, D., Yang, X., Smith, A. B., Sodroski, J., & Freire, E. (2006) · Biochemistry · doi:10.1021/bi061193r · Cited by 154
Fragment-based lead discovery: a chemical update
Erlanson, D. A. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.10.007 · Cited by 149
Revealing static and dynamic modular architecture of the eukaryotic protein interaction network
Komurov, K., & White, M. A. (2007) · Molecular Systems Biology · doi:10.1038/msb4100149 · Cited by 145
Hot-spot mimicry of a cytokine receptor by a small molecule
Thanos, C. D., DeLano, W. L., & Wells, J. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607058103 · Cited by 144
Self-citationIdentifying functional modules in the physical interactome of Saccharomyces cerevisiae
Pu, S., Vlasblom, J., Emili, A., Greenblatt, J. F., & Wodak, S. J. (2007) · PROTEOMICS · doi:10.1002/pmic.200600636 · Cited by 140
Tilley, J., Chen, L., Fry, D. C., Emerson, S. D., Powers, G. D., Biondi, D. A., Varnell, T. A., Trilles, R. V., Guthrie, R. W., Mennona, F. A., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja970702x · Cited by 129
Lee, L., & Tidor, B. (2001) · Protein Science · doi:10.1110/ps.40001 · Cited by 129
Midelfort, K. S., Hernández, H. H., Lippow, S. M., Tidor, B., Drennan, C. L., & Wittrup, K. D. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.08.019 · Cited by 128
Spencer, R. W. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(199824)61:1<61::aid-bit11>3.0.co;2-c · Cited by 123
Takasaki, W., Kajino, Y., Kajino, K., Murali, R., & Greene, M. I. (1997) · Nature Biotechnology · doi:10.1038/nbt1197-1266 · Cited by 121
Potent Small-Molecule Binding to a Dynamic Hot Spot on IL-2
Thanos, C. D., Randal, M., & Wells, J. A. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0382617 · Cited by 116
Self-citationRaimundo, B. C., Oslob, J. D., Braisted, A. C., Hyde, J., McDowell, R. S., Randal, M., Waal, N. D., Wilkinson, J., Yu, C. H., & Arkin, M. R. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049967u · Cited by 104
Viaud, J., Zeghouf, M., Barelli, H., Zeeh, J., Padilla, A., Guibert, B., Chardin, P., Royer, C. A., Cherfils, J., & Chavanieu, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700773104 · Cited by 102
Wang, Y., Coulombe, R., Cameron, D. R., Thauvette, L., Massariol, M.-J., Amon, L. M., Fink, D., Titolo, S., Welchner, E., Yoakim, C., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311376200 · Cited by 98
Tsao, D. H. H., Sutherland, A. G., Jennings, L. D., Li, Y., Rush, T. S., Alvarez, J. C., Ding, W., Dushin, E. G., Dushin, R. G., Haney, S. A., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.07.050 · Cited by 93
SAR by NMR: Putting the Pieces Together
Hajduk, P. J. (2006) · Molecular Interventions · doi:10.1124/mi.6.5.8 · Cited by 86
NMR structure of a complex between MDM2 and a small molecule inhibitor
Fry, D. C., Emerson, S. D., Palme, S., Vu, B. T., Liu, C., & Podlaski, F. (2004) · Journal of Biomolecular NMR · doi:10.1023/b:jnmr.0000048856.84603.9b · Cited by 83
Discovery of a novel small molecule binding site of human survivin
Wendt, M. D., Sun, C. C., Kunzer, A. R., Sauer, D. R., Sarris, K., Hoff, E. D., Yu, L. P., Nettesheim, D. G., Chen, J., Jin, S. S., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.042 · Cited by 82
The structure of a yeast hexokinase monomer and its complexes with substrates at 2.7-A resolution.
Fletterick, R. J., Bates, D. J., & Steitz, T. A. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.1.38 · Cited by 80
Sadowsky, J., Murray, J. K., Tomita, Y. A., & Gellman, S. H. (2007) · ChemBioChem · doi:10.1002/cbic.200600546 · Cited by 79
White, P. W., Titolo, S., Brault, K., Thauvette, L., Pelletier, A., Welchner, E., Bourgon, L., Doyon, L., Ogilvie, W. W., Yoakim, C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303608200 · Cited by 71
Exploring protein–ligand recognition with Binding MOAD
Smith, R. D., Hu, L., Falkner, J. A., Benson, M. L., Nerothin, J., & Carlson, H. A. (2005) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2005.08.002 · Cited by 69
Yoakim, C., Ogilvie, W. W., Goudreau, N., Naud, J., Haché, B., O’Meara, J. A., Cordingley, M. G., Archambault, J., & White, P. W. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00510-9 · Cited by 67
Jennings, L. D., Foreman, K. W., Rush, T. S., Tsao, D. H. H., Mosyak, L., Kincaid, S. L., Sukhdeo, M. N., Sutherland, A. G., Ding, W., Kenny, C. H., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.07.031 · Cited by 57
Effects of Conformational Dynamics on Predicted Protein Druggability
Brown, S. P., & Hajduk, P. J. (2006) · ChemMedChem · doi:10.1002/cmdc.200500013 · Cited by 56
Benzodiazepine peptidomimetic inhibitors of farnesyltransferase
Marsters, J. C., McDowell, R. S., Reynolds, M. E., Oare, D. A., Somers, T. C., Stanley, M. S., Rawson, T. E., Struble, M. E., Burdick, D. J., Chan, K. S., et al. (1994) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)82044-1 · Cited by 51
Emerson, S. D., Palermo, R. E., Liu, C., Tilley, J., Chen, L., Danho, W., Madison, V., Greeley, D. N., Ju, G., & Fry, D. C. (2003) · Protein Science · doi:10.1110/ps.0232803 · Cited by 51
Crystal structures of cyclophilin and its partners
Ke, H., & Huai, Q. (2004) · Frontiers in bioscience · doi:10.2741/1396 · Cited by 35
Discovery of Selective Small-Molecule CD80 Inhibitors
Uvebrant, K., Thrige, D. D. G., Rosén, A., Åkesson, M., Berg, H., Walse, B., & Björk, P. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107300464 · Cited by 29
Goudreau, N., Cameron, D. R., Déziel, R., Haché, B., Jakalian, A., Malenfant, É., Naud, J., Ogilvie, W. W., O’Meara, J. A., White, P. W., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.036 · Cited by 28
The protein network as a tool for finding novel drug targets
Strong, M., & Eisenberg, D. S. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7567-6_8 · Cited by 21
Cited by
The re-emergence of natural products for drug discovery in the genomics era
Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4510 · Cited by 2,572
Molecular Docking and Structure-Based Drug Design Strategies
Ferreira, L., Dos Santos, R., Oliva, G., & Andricopulo, A. (2015) · Molecules · doi:10.3390/molecules200713384 · Cited by 2,528
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
Thirumurugan, P., Matosiuk, D., & Jozwiak, K. (2013) · Chemical Reviews · doi:10.1021/cr200409f · Cited by 1,896
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Improved Docking of Polypeptides with Glide
Tubert-Brohman, I., Sherman, W., Repasky, M., & Beuming, T. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400128m · Cited by 1,308
Metadata
- Authors
- Wells, J. A., & McClendon, C. L.
- Venue
- Nature
- Published
- 2007-12
- Volume
- 450
- Issue
- 7172
- Pages
- 1001-1009
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2056169996
- Cited by
- 1,960
- References
- 98
- FWCI
- 117.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.